vlog

Object moved to here.

Measles and Measles Vaccination: A Review | Vaccination | JAMA Pediatrics | vlog

vlog

[Skip to Navigation]
Sign In
1.
Moss WJ, Griffin DE. Measles.Գ. 2012;379(9811):153-164.
2.
Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K; Centers for Disease Control and Prevention (CDC). Measles outbreak—California, December 2014-February 2015.MMWR Morb Mortal Wkly Rep. 2015;64(6):153-154.
3.
Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS; Centers for Disease Control and Prevention (CDC). Measles—United States, January 4–April 2, 2015.MMWR Morb Mortal Wkly Rep. 2015;64(14):373-376.
4.
Knol M, Urbanus A, Swart E, et al. Large ongoing measles outbreak in a religious community in the Netherlands since May 2013.Euro Surveill. 2013;18(36):20580.
5.
Measles once again endemic in the United Kingdom.Euro Surveill. 2008;13(27):18919.
6.
Orenstein WA, Papania MJ, Wharton ME. Measles elimination in the United States.J Infect Dis. 2004;189(suppl 1):S1-S3.
7.
Orenstein WA. The role of measles elimination in development of a national immunization program.Pediatr Infect Dis J. 2006;25(12):1093-1101.
8.
Brown KF, Kroll JS, Hudson MJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review.ղԱ. 2010;28(26):4235-4248.
9.
Leask J, Chapman S, Hawe P, Burgess M. What maintains parental support for vaccination when challenged by anti-vaccination messages? a qualitative study.ղԱ. 2006;24(49-50):7238-7245.
10.
Smith PJ, Marcuse EK, Seward JF, Zhao Z, Orenstein WA. Children and adolescents unvaccinated against measles: geographic clustering, parents’ beliefs, and missed opportunities.Public Health Rep. 2015;130(5):485-504.
11.
de Vries RD, Mesman AW, Geijtenbeek TBH, Duprex WP, de Swart RL. The pathogenesis of measles.Curr Opin Virol. 2012;2(3):248-255.
12.
Buchanan R, Bonthius DJ. Measles virus and associated central nervous system sequelae.Semin Pediatr Neurol. 2012;19(3):107-114.
13.
Anderson RM, May RM. Directly transmitted infections diseases: control by vaccination.Գ. 1982;215(4536):1053-1060.
14.
Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.Գ. 2015;348(6235):694-699.
15.
Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.Ѵ. 2010;340:c1626.
16.
Centers for Disease Control and Prevention. Public health image library: details: back of boy with measles; third day of rash. . Updated March 18, 2005. Accessed August 23, 2016.
17.
Centers for Disease Control and Prevention. Public health image library: details: this child with measles is showing the characteristic red blotchy rash on his buttocks and back during the 3rd day of the rash. . Updated March 18, 2005. Accessed August 23, 2016.
18.
Centers for Disease Control and Prevention. Public health image library: details: face of boy with measles; third day of rash. . Updated March 18, 2005. Accessed August 23, 2016.
19.
Case definitions for measles surveillance and outbreak investigation. In: Response to Measles Outbreaks in Measles Mortality Reduction Settings. Geneva, Switzerland: World Health Organization; March 2009:5.
20.
Centers for Disease Control and Prevention. Public health image library: details: this patient presented on the third pre-eruptive day with “Koplik spots” indicative of the beginning onset of measles. . Updated March 18, 2005. Accessed August 23, 2016.
21.
Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting.J Infect Dis. 2003;187(1)(suppl 1):S283-S290.
22.
Sampedro A, Rodríguez-Granger J, Gómez C, Lara A, Gutierrez J, Otero A. Comparative evaluation of a new chemiluminiscent assay and an ELISA for the detection of IgM against measles.J Clin Lab Anal. 2013;27(6):477-480.
23.
Akiyoshi K, Suga T, Nukuzuma S, et al. Reevaluation of laboratory methods for diagnosis of measles.Jpn J Infect Dis. 2010;63(4):225-228.
24.
Hutse V, Van Hecke K, De Bruyn R, et al. Oral fluid for the serological and molecular diagnosis of measles.Int J Infect Dis. 2010;14(11):e991-e997.
25.
Zhang D, Sun Y, Jia T, et al. External quality assessment for the detection of measles virus by reverse transcription-PCR using armored RNA.PLoS One. 2015;10(8):e0134681.
26.
Benamar T, Tajounte L, Alla A, et al. Real-time PCR for measles virus detection on clinical specimens with negative IgM result in Morocco.PLoS One. 2016;11(1):e0147154.
27.
Minagawa H, Yasui Y, Adachi H, et al. Case-based surveillance enhanced with measles virus detection/genotyping is essential to maintain measles elimination in Aichi Prefecture, Japan.ղԱ. 2015;33(45):6043-6048.
28.
Wang FJ, Sun XJ, Wang FL, Jiang LF, Xu EP, Guo JF. An outbreak of adult measles by nosocomial transmission in a high vaccination coverage community.Int J Infect Dis. 2014;26:67-70.
29.
Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases: measles. . Updated July 24, 2015. Accessed March 29, 2016.
30.
White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM. Measles, mumps, and rubella.Clin Obstet Gynecol. 2012;55(2):550-559.
31.
Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children.Cochrane Database Syst Rev. 2005;(4):CD001479.
32.
Sudfeld CR, Navar AM, Halsey NA. Effectiveness of measles vaccination and vitamin A treatment.Int J Epidemiol. 2010;39(s1)(suppl 1):i48-i55.
33.
American Academy of Pediatrics Committee on Infectious Diseases: vitamin A treatment of measles.ʱ徱ٰ. 1993;91(5):1014-1015.
34.
Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. ղԱs for measles, mumps and rubella in children.Cochrane Database Syst Rev. 2012;(2):CD004407.
35.
Mufson MA, Diaz C, Leonardi M, et al. Safety and immunogenicity of human serum albumin-free MMR vaccine in US children aged 12-15 months.J Pediatric Infect Dis Soc. 2015;4(4):339-348.
36.
Ma SJ, Li X, Xiong YQ, Yao AL, Chen Q. Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety.Medicine (Baltimore). 2015;94(44):e1721.
37.
Ma SJ, Xiong YQ, Jiang LN, Chen Q. Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: a systematic review and meta-analysis.ղԱ. 2015;33(31):3636-3649.
38.
Meissner HC, Strebel PM, Orenstein WA. Measles vaccines and the potential for worldwide eradication of measles.ʱ徱ٰ. 2004;114(4):1065-1069.
39.
Moss WJ, Strebel P. Biological feasibility of measles eradication.J Infect Dis. 2011;204(suppl 1):S47-S53.
40.
Measles vaccines: WHO position paper.Wkly Epidemiol Rec. 2009;84(35):349-360.
41.
Gay NJ. The theory of measles elimination: implications for the design of elimination strategies.J Infect Dis. 2004;189(S1)(suppl 1):S27-S35.
42.
Lievano F, Galea SA, Thornton M, et al. Measles, mumps, and rubella virus vaccine (M-M-RII): a review of 32 years of clinical and postmarketing experience.ղԱ. 2012;30(48):6918-6926.
43.
Allen A. Vaccines and autism? In: ղԱ: The Controversial Story of Medicine’s Greatest Lifesaver. New York, NY: Norton; 2007:371-420.
44.
Godlee F, Smith J, Marcovitch H. Wakefield’s article linking MMR vaccine and autism was fraudulent.Ѵ. 2011;342:c7452.
45.
Goldacre B. The media’s MMR hoax. In: Bad Science. Toronto, ON: McClelland & Stewart; 2008:208-252.
46.
American Academy of Pediatrics. Vaccine safety: examine the evidence. . Updated April 2013. Accessed April 1, 2016.
47.
Institute of Medicine. Immunization Safety Review: Vaccines and Autism. Washington, DC: National Academies Press; 2004.
48.
Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study.J Child Psychol Psychiatry. 2005;46(6):572-579.
49.
Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.ʱ徱ٰ. 2006;118(1):e139-e150.
50.
Centers for Disease Control and Prevention. Vaccines for Children Program (VFC): CDC vaccine price list. . Updated August 15, 2016. Accessed April 1, 2016.
51.
UNICEF. Facts on children: measles. . Updated April 2007. Accessed April 1, 2016.
52.
Zhou F, Reef S, Massoudi M, et al. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.J Infect Dis. 2004;189(suppl 1):S131-S145.
53.
Zwanziger J, Szilagyi PG, Kaul P. Evaluating the benefits of increasing measles immunization rates.Health Serv Res. 2001;36(5):885-909.
54.
Fiebelkorn AP, Redd SB, Gallagher K, et al. Measles in the United States during the postelimination era.J Infect Dis. 2010;202(10):1520-1528.
55.
World Health Organization. Measles reported cases. . Updated July 15, 2016. Accessed August 23, 2016.
56.
World Health Organization. Measles (MCV) data by country. . Accessed April 1, 2016.
57.
Perry RT, Murray JS, Gacic-Dobo M, et al. Progress towards regional measles elimination, worldwide, 2000–2014.Wkly Epidemiol Rec. 2015;90(46):623-631.
58.
World Health Organization. Number of reported measles cases with onset date from Nov 2015 to Apr 2016 (6M period). . Updated June 13, 2016. Accessed May 7, 2016.
Views 11,881
Review
ٱ𳦱𳾲2016

Measles and Measles Vaccination: A Review

Author Affiliations
  • 1Department of Bioethics, Cleveland Clinic, Cleveland, Ohio
  • 2Centre for Applied Ethics, University of Stellenbosch, Stellenbosch, South Africa
JAMA Pediatr. 2016;170(12):1209-1215. doi:10.1001/jamapediatrics.2016.1787
Key Points

Question What should primary care health care professionals know about measles and measles vaccination?

Findings This review provides an overview of measles for clinicians and includes information on virus basics, clinical picture and diagnosis, measles complications, vaccine efficacy, and vaccine complications. Health care professionals play important roles in vaccination uptake, diagnosis and management of acute cases of measles, and limiting spread during outbreaks.

Meaning Measles should be in the differential diagnosis of any child who presents with fever and erythematous rash, and the focus of the health care response to measles infection is prevention through vaccination.

Abstract

Importance Measles is a highly communicable viral infection with serious complications. There have been continued outbreaks of measles in countries in which measles is considered to be eliminated, such as the United States and the Netherlands, and measles remains endemic in some countries. Health care professionals play an important role in diagnosing and managing acute cases of measles, preventing spread during outbreaks, and vaccination uptake.

Objective To provide an overview of measles and vaccination for health care professionals.

Evidence Review MEDLINE and PubMed were searched from January 1, 1980, to April 30, 2016, in addition to the data repositories of the Centers for Disease Control and Prevention and World Health Organization.

Findings Seven systematic reviews, 15 reviews, 15 observational studies, 1 qualitative study, 5 epidemiologic reports, and 2 books were included, in addition to World Health Organization and Centers for Disease Control and Prevention data, position papers, and statements. Transmission of measles is dependent on person-to-person spread through respiratory droplets or direct contact. Diagnosis is based on recognizing the clinical picture and can be confirmed with results of laboratory testing, such as serologic tests or polymerase chain reaction. Measles infection leads to immune suppression for weeks to months. Complications of measles are of high frequency and severity. There is no specific antiviral treatment for measles; treatment with vitamin A is recommended for younger children to decrease mortality from measles. Vaccination against measles is effective, cost-effective, and safe. There is no link between the measles vaccination and autism. Measles can be eliminated from a population; this outcome requires coverage with 2 doses of vaccine at rates of 93% to 95% of the population. Countries with high rates of measles vaccination experience outbreaks by virtue of imported cases causing transmission through susceptible groups of individuals who are not immune to the measles virus. Endemic transmission can be reestablished if rates of vaccination fall below the elimination threshold.

Conclusions and Relevance Measles remains of high clinical importance. Health care professionals should be able to diagnose and manage an acute case and assist in prevention of the spread of measles during an outbreak. Health care professionals also play an important role in uptake of measles vaccination through establishing trusting relationships with parents, offering vaccination at indicated times, and engaging parents in discussion on facts and concerns about vaccination.

×